News from Zyme and the companies we work with.
H.E.L Group appoints Sales Director for Asia-Pacific
Brice Oh appointed to strengthen the Company’s position in the region and facilitate new commercial partnerships London, UK, 5th May 2021: H.E.L Group (H.E.L), a global developer and manufacturer of [...]
The FDA expands collaboration with CN Bio to investigate lung-on-a-chip model for inhaled drug evaluation applications
Extension aims to evaluate CN Bio’s PhysioMimix lung-on-a-chip platform in addition to deepening existing research collaboration for liver studies Follows success of initial project demonstrating the advanced performance of the [...]
Bio-Rad Launches Its Reliance SARS-CoV-2 RT-PCR Assay Kit in Europe
HERCULES, Calif.–May 04, 2021–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of the Reliance SARS-CoV-2 RT-PCR [...]
Mogrify completes Series A financing totaling $33 million USD
Second close of $17 million USD brings total raised in Series A to $33 million USD Funding led by Parkwalk Advisors with participation from strategic investor: Astellas Venture Management, as [...]
Turbine strengthens R&D capabilities with key appointments
Biotech entrepreneur Mark Velleca is Board Chair, seasoned cancer biology advisors Gordon Mills and Klaus Hoeflich join Scientific Advisory Board London, UK, Budapest, Hungary, 28 April 2021: Turbine, a company [...]
H.E.L Group signs distribution agreement with ThalesNano Energy for H-Genie bench-top high-pressure hydrogen generator
H-Genie smart, high pressure hydrogen generator now available alongside H.E.L’s catalysis product range Provides bench-top access to 100-bar hydrogen gas, removing the need for cylinders or in-line supply London, UK, [...]
The Native Antigen Company Launches SARS-CoV-2 Neutralisation Assay Development Kit
Kit enables identification and qualitative measurement of neutralising antibodies to support characterisation of SARS-CoV-2 variants and monitoring of vaccine efficacy Oxford, UK, 22 April 2021: The Native Antigen Company, part [...]
Bio-Rad Launches SARS-CoV-2 Variant RT-PCR Assays
The Assays Help Public Health Researchers Track SARS-CoV-2 Variants More Rapidly and Cost-Effectively HERCULES, Calif.–April 21, 2021–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research [...]
Avacta receives clinical validation of AffiDX SARS-CoV-2 antigen lateral flow test
98.0% clinical sensitivity for samples with PCR Ct values1 up to 31 Completing the technical data set for self-declaration of a CE mark for professional use in early May, followed [...]
Adaptate Biotherapeutics Raises $18 million in Series A2 Funding
Investment will accelerate the progression of the Company’s lead therapeutic antibody programme towards the clinic and further expand its internal product pipeline Latest financing takes total funds raised to $34 [...]
ERS Genomics and NUVISAN ICB sign CRISPR/Cas9 license agreement
CRISPR offerings to enhance NUVISAN’s drug development service portfolio Dublin, Ireland and Berlin, Germany, 19 April 2021: ERS Genomics Limited, which was formed to provide broad access to the foundational [...]
Metrion Biosciences appoints Mark Keogh as Non-Executive Director
Appointment strengthens the financial and corporate experience of Metrion’s Board in support of the Company’s planned international growth Cambridge, UK, 19 April 2021: Metrion Biosciences Limited (“Metrion”), the specialist ion [...]
